SCHEMBL1573928

SCHEMBL1573928

CS(=O)(=O)Nc1ccc(Cc2noc([C@@H]3C[C@H]4CC[C@@H](C3)N4)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HTR2C P28335 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 1/20 0.44
HTT P42858 1/20 0.44
GRM5 P41594 1/20 0.36
TSHR P16473 1/20 0.35
CTSK P43235 1/20 0.35
CTSC P53634 1/20 0.35
GSK3B P49841 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573931 1.00 KDM4E (0.44) KDM4EMAPTHPGDCYP1A2CYP3A4
SCHEMBL14514101 0.85 KDM4E (0.46) KDM4EMAPTHPGDCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL5635304 0.84 KDM4E (0.45) KDM4EMAPTHPGDCYP1A2CYP3A4
SCHEMBL1574030 0.81 KDM4E (0.40) KDM4EMAPTHPGDCYP1A2CYP3A4
SCHEMBL5635023 0.75 GRM5 (0.36) KDM4EMAPTHPGDCYP1A2CYP3A4
SCHEMBL5635025 0.74 GPR119 (0.53) SMN1; SMN2GPR119
SCHEMBL21434913 0.72 ALDH1A1 (0.42) KDM4EMAPTHPGDLMNASMN1; SMN2
SCHEMBL14514107 0.72 CCR5 (0.43) KDM4EMAPTHPGDCYP1A2CYP3A4
SCHEMBL1573880 0.72 CCR5 (0.44)
SCHEMBL1573882 0.72 CCR5 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed